亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Therapeutic vulnerabilities among KRAS G12C mutant (mut) advanced cancers based on co-alteration (co-alt) patterns.

克拉斯 医学 STK11段 癌症 结直肠癌 PTEN公司 恶性肿瘤 癌症研究 肿瘤科 内科学 信号转导 生物 遗传学 PI3K/AKT/mTOR通路
作者
Maliha Nusrat,Jason Roszik,Vijaykumar Holla,Tiantian Cai,Meiyue Hong,Oluwadara Coker,Benny Johnson,Jordi Rodón Ahnert,Filip Janků,Scott Kopetz,Kenna Shaw,Funda Meric‐Bernstam,David S. Hong
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:38 (15_suppl): 3625-3625 被引量:8
标识
DOI:10.1200/jco.2020.38.15_suppl.3625
摘要

3625 Background: Oncogenic KRAS mut drive cancers and confer therapeutic resistance by activating MAPK signaling. Inhibiting KRAS has been elusive until the recent promising phase I trials with KRAS G12C inhibitors (i). We characterized frequencies of KRAS G12C mut and gene co-alt among advanced cancer patients (pts) to identify therapeutic vulnerabilities for combination development. Methods: We analyzed next generation sequencing datasets from MD Anderson Cancer Center (MDACC, n = 42,316) and AACR GENIE (n = 56,970). Genes and individual alterations were annotated for potential actionability with approved or investigational drugs and grouped into 12 oncogenic pathways. Frequencies of potential drug combinations with KRAS G12Ci were estimated per tumor type based on co-occurrence of potentially actionable alterations. Results: KRAS G12C was present in 850/34,801 (2.4%) advanced solid tumor and 22/7698 (0.3%) hematologic malignancy pts in MDACC dataset; and 1422 (2.5%) pts in AACR GENIE. Among solid tumor pts, 798 had histology data and 640 had ≥46 gene profiling. Most common cancers were non-small cell lung (NSCLC, 67%), colorectal (CRC, 24%), other gastrointestinal (oGI, 4%) and gynecologic (gyn, 2%). KRAS G12C prevalence was 19.5% (441/2265) in NSCLC and 4.2% (146/3469) in CRC. Genes most commonly co-altered were TP53 (42%), STK11 (17%) and MET (11%) in NSCLC; TP53 (58%), APC (54%) and PIK3CA (24%) in CRC; TP53 (42%), APC (21%) and ATM (21%) in oGI; TP53 (56%), PIK3CA (25%), and PTEN (19%) in gyn cancers. These co-alt did not impact overall survival. In both datasets, as compared to KRAS wild, KRAS G12C was significantly co-altered with STK11 in NSCLC; PIK3CA and SMAD4 in CRC (P < 0.05 for all). EGFR mut in NSCLC and BRAF mut in CRC rarely co-occurred with KRAS G12C (P < 0.01). Most frequently co-altered oncogenic pathways in NSCLC, CRC, oGI and gyn cancers respectively included PI3K (27, 32, 33, 44 %), receptor tyrosine kinases (13, 16, 42, 13 %) and DNA damage repair (12, 10, 38, 19 %). Potentially actionable co-alt frequencies suggest that combining KRAS G12Ci with mTORi or PI3Ki would be indicated most frequently, in 24% and 13% of all pts respectively. Conclusions: KRAS G12Ci development is most relevant for NSCLC, gastrointestinal and gyn cancers. The co-alt patterns highlight relevant oncogenic pathways and candidate drugs for future combination therapies. Co-inhibition of PI3K-mTOR and MAPK pathways has shown synergism in prior pre-clinical studies but had poor tolerance in pts. There is opportunity to revisit this approach with the new KRAS G12Ci.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
冰留完成签到 ,获得积分10
10秒前
27秒前
量子星尘发布了新的文献求助10
42秒前
852应助feiying采纳,获得10
1分钟前
无花果应助breeze采纳,获得10
1分钟前
隐形曼青应助Master采纳,获得10
1分钟前
1分钟前
Master发布了新的文献求助10
1分钟前
2分钟前
量子星尘发布了新的文献求助10
2分钟前
领导范儿应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
al完成签到 ,获得积分10
2分钟前
2分钟前
早早发布了新的文献求助10
2分钟前
科研通AI5应助Djnsbj采纳,获得10
3分钟前
3分钟前
量子星尘发布了新的文献求助10
3分钟前
3分钟前
顺心蜜粉发布了新的文献求助200
3分钟前
3分钟前
Djnsbj发布了新的文献求助10
4分钟前
4分钟前
breeze发布了新的文献求助10
4分钟前
我是老大应助科研通管家采纳,获得10
4分钟前
Daisy完成签到,获得积分10
4分钟前
4分钟前
量子星尘发布了新的文献求助150
4分钟前
自由的无色完成签到 ,获得积分10
5分钟前
ZHH完成签到,获得积分10
5分钟前
5分钟前
feiying发布了新的文献求助10
5分钟前
滕皓轩完成签到 ,获得积分20
5分钟前
feiying完成签到,获得积分10
5分钟前
CodeCraft应助Djnsbj采纳,获得10
5分钟前
6分钟前
6分钟前
6分钟前
量子星尘发布了新的文献求助10
6分钟前
KSung完成签到 ,获得积分10
6分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976665
求助须知:如何正确求助?哪些是违规求助? 3520756
关于积分的说明 11204743
捐赠科研通 3257502
什么是DOI,文献DOI怎么找? 1798733
邀请新用户注册赠送积分活动 877897
科研通“疑难数据库(出版商)”最低求助积分说明 806629